Sold in nasal spray form, the product is often marketed with Barbie-inspired designs, pink packaging and stamped with a seemingly official “Barbie” logo ... by the FDA, meaning the product ...

Sold in nasal spray form, the product is often marketed with Barbie-inspired designs, pink packaging, and stamped with a seemingly official “Barbie” logo ... by the FDA, meaning the product ...

The FDA's accelerated approval of Emrelis was based on a mid-stage trial of 84 patients, where the drug showed an overall response rate of 35%. It is currently being evaluated in a late-stage trial.

The drug, Welireg, became the first FDA-approved oral treatment for pheochromocytoma and paraganglioma (PPGL), providing a convenient option for up to 2,000 patients diagnosed with these tumors in ...

Five years after the COVID-19 pandemic gripped the world, the U.S. FDA is moving away from annual routine boosters for all children and adults. Instead of that one-size-fits-all regulatory framework ...

Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the HADLIMA™ (adalimumab-bwwd) high- and low-concentration ...

Sunny, one of the two young bald eagles in Big Bear Valley, California, born back in March, took flight for a few seconds on ...

“It gives us hope, as volunteers ... Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans. DiBrango says there is no ...

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two rare types of adrenal gland tumors. The drug, Welireg ...

Low US representation During Tuesday’s public meeting, the FDA went beyond the efficacy analysis to also question the composition of the trial participants and the relevance of Starglo’s ...

“Australia is a smart strategic choice — it allows biotechs to start faster, control costs, reduce burn rate, and generate FDA-accepted data without the delays and complexity of the US IND ...

Independent experts voted eight-to-one that the results of a pivotal Roche trial, which enrolled just 9% of its total patients from the US, weren ... working with the FDA on a regulatory path ...